国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2008年
6期
441-443
,共3页
癌,非小细胞肺%药物疗法,联合
癌,非小細胞肺%藥物療法,聯閤
암,비소세포폐%약물요법,연합
Carcinoma,non-small-cell lung%Drug therapy,combination
维持化疗对晚期非小细胞肺癌(NSCLC)可延长生存期.诱导化疗方案中证实有效的药物可用于维持化疗,二线、三线化疗药物及分子靶向药物似乎更适合用于晚期NSCLC维持化疗.
維持化療對晚期非小細胞肺癌(NSCLC)可延長生存期.誘導化療方案中證實有效的藥物可用于維持化療,二線、三線化療藥物及分子靶嚮藥物似乎更適閤用于晚期NSCLC維持化療.
유지화료대만기비소세포폐암(NSCLC)가연장생존기.유도화료방안중증실유효적약물가용우유지화료,이선、삼선화료약물급분자파향약물사호경괄합용우만기NSCLC유지화료.
Maintenance chemotherapy may prolong survival time in advanced non-small-cell lung canc-er. Maintenance chemotherapy may use the effective drugs which have been used in induction chemotherapy and the second-or third-line chemotherapy and molecular target drugs seem more fit for maintenance chemotherapy in advanced non-small-cell lung cancer.
